Literature DB >> 8864193

A transgenic mouse prostate cancer model.

J R Gingrich1, N M Greenberg.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8864193     DOI： 10.1177/019262339602400414

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN： 0192-6233            Impact factor:   1.902


× No keyword cloud information.
  38 in total

1.  Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.

Authors:  E D Kwon; A A Hurwitz; B A Foster; C Madias; A L Feldhaus; N M Greenberg; M B Burg; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?

Authors:  Hua Xu; Meng-Bo Hu; Pei-de Bai; Wen-Hui Zhu; Qiang Ding; Hao-Wen Jiang
Journal:  Int Urol Nephrol       Date:  2014-08-27       Impact factor: 2.370

3.  Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP.

Authors:  Yana K Reshetnyak; Lan Yao; Sida Zheng; Sergey Kuznetsov; Donald M Engelman; Oleg A Andreev
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

4.  Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.

Authors:  Rana P Singh; Komal Raina; Girish Sharma; Rajesh Agarwal
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

5.  Anaplastic renal carcinoma expressing SV40 T antigen in a female TRAMP mouse.

Authors:  Erin M Goodwin; Qing Zhong; Catherine S Abendroth; Lindsay K Ward-Kavanagh; Todd D Schell; Timothy K Cooper
Journal:  Comp Med       Date:  2013-08       Impact factor: 0.982

Review 6.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

7.  Zinc-sensitive MRI contrast agent detects differential release of Zn(II) ions from the healthy vs. malignant mouse prostate.

Authors:  M Veronica Clavijo Jordan; Su-Tang Lo; Shiuhwei Chen; Christian Preihs; Sara Chirayil; Shanrong Zhang; Payal Kapur; Wen-Hong Li; Luis M De Leon-Rodriguez; Angelo J M Lubag; Neil M Rofsky; A Dean Sherry
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-25       Impact factor: 11.205

8.  Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.

Authors:  Kayvan R Keshari; Renuka Sriram; Mark Van Criekinge; David M Wilson; Zhen J Wang; Daniel B Vigneron; Donna M Peehl; John Kurhanewicz
Journal:  Prostate       Date:  2013-03-26       Impact factor: 4.104

9.  Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.

Authors:  Komal Raina; Subapriya Rajamanickam; Rana P Singh; Gagan Deep; Manesh Chittezhath; Rajesh Agarwal
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

Review 10.  The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.

Authors:  Sheng-Qiang Yu; Kuo-Pao Lai; Shu-Jie Xia; Hong-Chiang Chang; Chawnshang Chang; Shuyuan Yeh
Journal:  Asian J Androl       Date:  2008-12-22       Impact factor: 3.285
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.